These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9570906)

  • 21. Increased activity of porphobilinogen deaminase in erythrocytes during attacks of acute intermittent porphyria.
    Kostrzewska E; Gregor A
    Ann Clin Res; 1986; 18(4):195-8. PubMed ID: 3789651
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Validation and evaluation of two porphobilinogen deaminase activity assays for diagnosis of acute intermittent porphyria.
    Lin CN; Huang YC; Ro LS; Liao MF; Ning HC; Kuo HC
    Clin Chim Acta; 2018 Apr; 479():1-6. PubMed ID: 29317194
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Catecholamine uptake, accumulation, and release in acute porphyria.
    Beal MF; Atuk NO; Westfall TC; Turner SM
    J Clin Invest; 1977 Nov; 60(5):1141-8. PubMed ID: 908757
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Changes in the heme metabolic pathway in diabetic patients].
    Caballero F; Gerez E; Polo C; Mompo O; Vázquez E; Schultz R; Bernabó J; Batlle A
    Medicina (B Aires); 1995; 55(2):117-24. PubMed ID: 7565048
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of volatile anaesthetics on heme metabolism in a murine genetic model of Acute Intermittent Porphyria. A comparative study with other porphyrinogenic drugs.
    Ruspini SF; Zuccoli JR; Lavandera JV; Martínez MDC; Oliveri LM; Gerez EN; Batlle AMDC; Buzaleh AM
    Biochim Biophys Acta Gen Subj; 2018 Jun; 1862(6):1296-1305. PubMed ID: 29476795
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute intermittent porphyria: prevalence of mutations in the porphobilinogen deaminase gene in blood donors in France.
    Nordmann Y; Puy H; Da Silva V; Simonin S; Robreau AM; Bonaiti C; Phung LN; Deybach JC
    J Intern Med; 1997 Sep; 242(3):213-7. PubMed ID: 9350165
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determination of porphobilinogen deaminase activity in human erythrocytes: pertinent factors in obtaining optimal conditions for measurements.
    Erlandsen EJ; Jørgensen PE; Markussen S; Brock A
    Scand J Clin Lab Invest; 2000 Nov; 60(7):627-34. PubMed ID: 11202055
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Family evaluations in acute intermittent porphyria using red cell uroporphyrinogen I synthetase.
    Lamon JM; Frykholm BC; Tschudy DP
    J Med Genet; 1979 Apr; 16(2):134-9. PubMed ID: 458830
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [New aspects in the pathogenesis of anemia in chronic polyarthritis].
    Linkesch W; Müller M; Scherak O
    Acta Med Austriaca Suppl; 1979; 6():387-9. PubMed ID: 299239
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Availability of porphobilinogen controls appearance of porphobilinogen deaminase activity in Escherichia coli K-12.
    Umanoff H; Russell CS; Cosloy SD
    J Bacteriol; 1988 Oct; 170(10):4969-71. PubMed ID: 3049558
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Erythropoietin controls heme metabolic enzymes in normal human bone marrow culture.
    Abraham NG; Nelson JC; Ahmed T; Konwalinka G; Levere RD
    Exp Hematol; 1989 Sep; 17(8):908-13. PubMed ID: 2767184
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute intermittent porphyria in two patients on anticonvulsant therapy and with normal erythrocyte porphobilinogen deaminase activity.
    Herrick AL; McColl KE; Moore MR; Brodie MJ; Adamson AR; Goldberg A
    Br J Clin Pharmacol; 1989 Apr; 27(4):491-7. PubMed ID: 2497768
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Porphyrin biosynthesis and enzymatic studies in erythrocytes from normals and porphyric humans.
    Parera VE; Stella AM; Wider de Xifra EA; Fukuda H; Batlle AM
    Int J Biochem; 1980; 12(5-6):947-53. PubMed ID: 7450154
    [No Abstract]   [Full Text] [Related]  

  • 34. The third case of Doss porphyria (delta-amino-levulinic acid dehydratase deficiency) in Germany.
    Doss MO; Stauch T; Gross U; Renz M; Akagi R; Doss-Frank M; Seelig HP; Sassa S
    J Inherit Metab Dis; 2004; 27(4):529-36. PubMed ID: 15303011
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Normal reference ranges for urinary δ-aminolevulinic acid and porphobilinogen levels.
    Agarwal S; Habtemarium B; Xu Y; Simon AR; Kim JB; Robbie GJ
    JIMD Rep; 2021 Jan; 57(1):85-93. PubMed ID: 33473344
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunological determination of porphobilinogen deaminase as a diagnostic measure in acute intermittent porphyria.
    Lannfelt L
    J Clin Chem Clin Biochem; 1990 May; 28(5):273-8. PubMed ID: 2380662
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Photodynamic and light independent action of 8 to 2 carboxylic free porphyrins on some haem-enzymes.
    Afonso SG; Enríquez de Salamanca R; Batlle A
    Int J Biochem Cell Biol; 2001 Dec; 33(12):1208-14. PubMed ID: 11606257
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heme biosynthesis in sideroblastic anemia.
    Pasanen AV; Salmi M; Vuopio P; Tenhunen R
    Int J Biochem; 1980; 12(5-6):969-74. PubMed ID: 7450158
    [No Abstract]   [Full Text] [Related]  

  • 39. [Heme synthesis and iron status in pregnancy].
    Linkesch W; Pavelka R; Kofler E; Müller M
    Acta Med Austriaca Suppl; 1979; 6():368-72. PubMed ID: 299236
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In inherited porphyrias, lead intoxication is a toxogenetic disorder.
    Batlle AM; Fukuda H; Parera VE; Wider E; Stella AM
    Int J Biochem; 1987; 19(8):717-20. PubMed ID: 3622905
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.